Back to top
more

Augmedix (AUGX)

(Delayed Data from NSDQ)

$2.33 USD

2.33
59,827

0.00 (0.00%)

Updated Sep 18, 2024 04:00 PM ET

After-Market: $2.33 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value C Growth D Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 24% (60 out of 250)

Industry: Medical Info Systems

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Augmedix, Inc. (AUGX) Reports Q2 Loss, Lags Revenue Estimates

by Zacks Equity Research

Augmedix (AUGX) delivered earnings and revenue surprises of -33.33% and 0.08%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?

Aveanna Healthcare (AVAH) Beats Q2 Earnings and Revenue Estimates

by Zacks Equity Research

Aveanna (AVAH) delivered earnings and revenue surprises of 150% and 2.22%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?

Health Catalyst (HCAT) Q1 Earnings Beat Estimates

by Zacks Equity Research

Health Catalyst (HCAT) delivered earnings and revenue surprises of 66.67% and 0.11%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

How Much Upside is Left in Augmedix, Inc. (AUGX)? Wall Street Analysts Think 36.67%

by Zacks Equity Research

The consensus price target hints at a 36.7% upside potential for Augmedix, Inc. (AUGX). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Augmedix, Inc. (AUGX) is on the Move, Here's Why the Trend Could be Sustainable

by Zacks Equity Research

Augmedix, Inc. (AUGX) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.

Privia Health (PRVA) Q3 Earnings Miss Estimates

by Zacks Equity Research

Privia Health (PRVA) delivered earnings and revenue surprises of -16.67% and 1.59%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?

Definitive Healthcare Corp. (DH) Soars 7.1%: Is Further Upside Left in the Stock?

by Zacks Equity Research

Definitive Healthcare Corp. (DH) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Augmedix, Inc. (AUGX) Soars 7.6%: Is Further Upside Left in the Stock?

by Zacks Equity Research

Augmedix, Inc. (AUGX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

Augmedix, Inc. (AUGX) is on the Move, Here's Why the Trend Could be Sustainable

by Zacks Equity Research

If you are looking for stocks that are well positioned to maintain their recent uptrend, Augmedix, Inc. (AUGX) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.

Zacks.com featured highlights include Lifeway Foods, Augmedix and Clearwater Analytics

by Zacks Equity Research

Lifeway Foods, Augmedix and Clearwater Analytics are part of the Zacks Screen of the Week article.

Tirthankar Chakraborty headshot

3 Best Breakout Stocks to Buy Now for Solid Returns

by Tirthankar Chakraborty

Lifeway Foods (LWAY), Augmedix (AUGX) and Clearwater Analytics Holdings (CWAN) have been selected as the breakout stocks for today.

Augmedix, Inc. (AUGX) is on the Move, Here's Why the Trend Could be Sustainable

by Zacks Equity Research

Augmedix, Inc. (AUGX) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.

Zacks Industry Outlook Highlights P3 Health Partners, Talkspace and Augmedix

by Zacks Equity Research

P3 Health Partners, Talkspace and Augmedix are pat of the Zacks Industry Outlook article.

Urmimala Biswas headshot

3 Medical Info Systems Stocks to Buy as Industry Trends Improve

by Urmimala Biswas

Zacks Medical Info Systems industry stocks like P3 Health Partners (PIII), Talkspace (TALK) and Augmedix (AUGX) are expected to gain from the new normal trends.

Are Medical Stocks Lagging Augmedix (AUGX) This Year?

by Zacks Equity Research

Here is how Augmedix, Inc. (AUGX) and Intuitive Surgical, Inc. (ISRG) have performed compared to their sector so far this year.

Recent Price Trend in Augmedix, Inc. (AUGX) is Your Friend, Here's Why

by Zacks Equity Research

Augmedix, Inc. (AUGX) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.

Can Augmedix, Inc. (AUGX) Climb 36.06% to Reach the Level Wall Street Analysts Expect?

by Zacks Equity Research

The average of price targets set by Wall Street analysts indicates a potential upside of 36.1% in Augmedix, Inc. (AUGX). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Is Artivion (AORT) Outperforming Other Medical Stocks This Year?

by Zacks Equity Research

Here is how Artivion (AORT) and Augmedix, Inc. (AUGX) have performed compared to their sector so far this year.

Wall Street Analysts See a 32.11% Upside in Augmedix, Inc. (AUGX): Can the Stock Really Move This High?

by Zacks Equity Research

The consensus price target hints at a 32.1% upside potential for Augmedix, Inc. (AUGX). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Augmedix, Inc. (AUGX) Is a Great Choice for 'Trend' Investors, Here's Why

by Zacks Equity Research

Augmedix, Inc. (AUGX) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.

Augmedix, Inc. (AUGX) Reports Q2 Loss, Tops Revenue Estimates

by Zacks Equity Research

Augmedix, Inc. (AUGX) delivered earnings and revenue surprises of 7.69% and 3.55%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

Zacks Industry Outlook Highlights Definitive Healthcare, Clover Health and Augmedix

by Zacks Equity Research

Healthcare, Clover Health and Augmedix are part of the Zacks Industry Outlook article.

Abhinab Dasgupta headshot

Beat the Market Like Zacks: Shopify, Medtronic, Oracle in Focus

by Abhinab Dasgupta

Last week, our time-tested methodologies served investors well in navigating the market. Check out some of our achievements from the past three months.

Urmimala Biswas headshot

3 Medical Info Systems Stocks to Consider From a Prospering Industry

by Urmimala Biswas

Zacks Medical Info Systems industry stocks like Definitive Healthcare (DH), Clover Health Investments (CLOV) and Augmedix (AUGX) are expected to gain from new normal trends.

Here's Why Momentum in Augmedix, Inc. (AUGX) Should Keep going

by Zacks Equity Research

If you are looking for stocks that are well positioned to maintain their recent uptrend, Augmedix, Inc. (AUGX) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.